“…Of these agents, except for DPI 201-106 (20), inhibition of cyclic AMP phosphodiesterase (PDE) and a resultant increase in intracellular cyclic AMP in myocardium have been proposed to be involved as a mechanism for the positive inotropic effect, although this may not be the sole mechanism. Indeed, PDE inhibitory activity in crude enzyme or purified enzyme (isozyme III) preparations has been demonstrated for amrinone (21,22), sulmazole (23-25), MDL 17043 (6, 25), milrinone (7), piroximone (11), OPC-8212 (13), UD-CG 115 BS (14), and APP 201-533 (18). Elevation of intra cellular cyclic AMP in myocardium at drug concentrations producing a positive inotropic effect has been demonstrated for amrinone (21,22), sulmazole (25), MDL 17043 (25), milrinone (7), piroximone (26), OPC-8212 (13,27), UD-CG 115 BS (14), and APP 201-533 (19).…”